ruxolitinib
novartis,incyte
['ruxolitinib', '2018', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)']
very interesting presentation by on the use of maat013 (fmt) to treat gi-#gvhd.
notably, highly effective in sr and ruxolitinib-refractory patients.
a new "standard" third line therapy? #ash22 